SST and Alzheimer disease: Our results contribute to the growing body of evidence suggesting critical involvement of SST+ interneurons in the pathogenesis of AD, with RBFOX1 and KIF26B (previously identified as candidate AD-protective genes from rare genetic variants [57, 71]) appearing as markers of protected SST+ interneurons (Figure S20 and Tables S21 and S22).